Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

VectorBuilder Plans $500 Million Gene Therapy Delivery CDMO in Guangzhou

publication date: Apr 14, 2022

VectorBuilder, a CDMO based in Chicago, announced plans to build a $500 million gene delivery manufacturing and research campus in Guangzhou. When finished, the site will include 30 production suites designed to manufacture lentivirus, plasmids, messenger RNA, adeno-associated virus, cell lines and other types of viral and non-viral vectors. VectorBuilder says it offers gene therapy delivery services so biopharmas can focus on their candidates instead of developing their own vectors. The new Guangzhou campus, which will take four years to complete, is part of a global expansion. More details....

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here